Interest in stenting for the treatment of symptomatic high-grade intracranial atherosclerosis may be rekindled after the results of a new trial showing lower rates of in-stent restenosis and stroke ...

Iron bioresorbable scaffold achieves noninferior angiographic and clinical outcomes versus drug eluting stent at 2 years in ...

Dear Dr. Roach: I need an objective opinion. I’m an active 75-year-old male who had two drug-eluting stents placed in my heart approximately seven months ago. I have noticed no difference. I have low ...

Drug-eluting stents are small, wire scaffolds that are inserted into coronary arteries that have become narrow due to the development of atherosclerosis. The stent helps to hold the artery open and ...

Patients with diabetes have an increased risk of complications after stent implantation, according to a study from Karolinska Institutet in Sweden published in Diabetes Care. The study, which includes ...

Over the past decade, drug-eluting stents (DES) have greatly transformed the field of interventional cardiology. Generally, three components are included in a DES system: a metal stent platform, a ...

Drug-eluting stents have greatly reduced the risk of repeat blockage of heart arteries, but researchers from Northwestern Memorial Hospital have found that in some patients, the stents can cause ...

Figure 1. Colorized scanning electron microscope (SEM) image of a biodegradable drug-eluting coating on a coronary stent. Catheter-based interventions have revolutionized the practice of ...

Patients receiving newer-generation drug-eluting stents have similar rates of death or spontaneous myocardial infarction than those receiving contemporary bare-metal stents, but the rate of repeat ...

Drug-eluting stents are primarily used in patients with atherosclerosis, to open up narrowed and obstructed coronary arteries. Patients who have suffered a cardiac event such as a heart attack due to ...

Medtronic is recruiting patients for a randomized clinical trial that will investigate one-month dual-antiplatelet therapy (DAPT) in patients who have been implanted with Resolute Onyx, the company’s ...

Drug-eluting stents are an established treatment option for coronary artery disease, although they are not without their problems. The MAHOROBA ® stent attempts to harness the theoretical advantages ...